Apr 27 2018
What to Expect From Allergan, Aetna, Merck and Pfizer’s Earnings Next Week
Mizuho | TheStreet
Apr 26 2018
ViewPoints: Sloppiness not safety a big relief for Celgene’s ozanimod
Mizuho | FirstWord Pharma
Apr 26 2018
Investors Are Angry with Botox Maker Allergan & They’re Trying to Get an Activist Involved to Shake Things Up
Mizuho | Business Insider